Characterization and Biological Activity of Magnesium Nanoparticles Synthesized from Escherichia coli Metabolites Against Multidrug-Resistant Bacteria
Bacteria · 10.09.2025 · 4 (3) · 48
DOI: 10.3390/bacteria4030048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bacteria, online erschienen am 10.09.2025. Verfasst von Malak Mezher und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
This study evaluated the efficacy of magnesium nanoparticles (MgNPs) synthesized through a green method utilizing bacterial metabolites (BMs) produced by Escherichia coli. (2)
Methods
BMs were tested for total phenolic content by high-performance liquid chromatography. MgNPs were characterized by X-ray diffraction, transmission electron microscopy, Fourier transform infrared spectroscopy, photoluminescence, and ultraviolet–visible spectroscopy. MgNPs and BMs were tested for antibacterial and antibiofilm potentials against multidrug-resistant clinical isolates by agar well diffusion, minimum inhibitory and bactericidal concentration assays, time–kill test, and inhibition of biofilm formation and destruction of pre-formed biofilm assays. Furthermore, they were tested for antioxidant potential by 2,2-diphenyl-1-picryhydrazyl radical scavenging assay. (3)
Results
BMs included carbohydrates, reducing sugars, and phenols (gallic acid and catechin) with a total phenolic content of 0.024 mg GAE/g. MgNPs showed a pure crystalline structure with a spherical shape, 17.8 nm in size, and a 4.19 eV energy gap. Bacteria included Streptococcus pneumonia, Enterococcus faecium, Klebsiella pneumonia, and Salmonella Typhimurium. The antibacterial results showed inhibition zones ranging between 7.2 and 10.4 mm, a bactericidal effect of MgNPs, a bacteriostatic effect of BMs, and growth inhibition after 3 h. The antibiofilm results demonstrated significant inhibition of biofilm formation (inhibition percentages of 64.931% for MgNPs and 71.407% for BMs). However, the assays revealed modest biofilm destruction (eradication percentages of 48.667% for MgNPs and 37.730% for BMs). Antioxidant capacity revealed notable scavenging activity of MgNPs (scavenging activity of 41.482%) and weak activity of BMs (scavenging activity of 16.460%). (4)
Conclusions
These findings support the application of MgNPs in biomedical fields.
Zitieren
APA
Mezher, M., Khazaal, S., Khalil, M. I., Badan, D. E., & Hamdalla, T. A. (2025). Characterization and Biological Activity of Magnesium Nanoparticles Synthesized from Escherichia coli Metabolites Against Multidrug-Resistant Bacteria. Bacteria, 4(3), 48. https://doi.org/10.3390/bacteria4030048
Vancouver
Mezher M, Khazaal S, Khalil MI, Badan DE, Hamdalla TA. Characterization and Biological Activity of Magnesium Nanoparticles Synthesized from Escherichia coli Metabolites Against Multidrug-Resistant Bacteria. Bacteria. 2025;4(3):48. doi:10.3390/bacteria4030048
BibTeX
@article{Mezher2025,
author = {Mezher, Malak and Khazaal, Salma and Khalil, Mahmoud I. and Badan, Dalia El and Hamdalla, Taymour A.},
title = {Characterization and Biological Activity of Magnesium Nanoparticles Synthesized from Escherichia coli Metabolites Against Multidrug-Resistant Bacteria},
journal = {Bacteria},
year = {2025},
volume = {4},
number = {3},
pages = {48},
doi = {10.3390/bacteria4030048}
}
EUVIMED